30:I[703058,["/_next/static/immutable/chunks/3bhq_5eh1d760.js","/_next/static/immutable/chunks/1855-ogyi8eh4.js","/_next/static/immutable/chunks/2pfsjpn6k6zlg.js","/_next/static/immutable/chunks/26c7v3_3uwnwu.js","/_next/static/immutable/chunks/25a3ozcrvi1ff.js","/_next/static/immutable/chunks/2r4wx50nvjh_4.js","/_next/static/immutable/chunks/23fsw06hsi5b1.js","/_next/static/immutable/chunks/06_yt270h41rg.js","/_next/static/immutable/chunks/3ezsiz-7shkna.js","/_next/static/immutable/chunks/20x2y96ldu5wx.js","/_next/static/immutable/chunks/2lxntcm3pd1_h.js","/_next/static/immutable/chunks/00dgco8irq3jw.js","/_next/static/immutable/chunks/00nwe-kq0rboc.js","/_next/static/immutable/chunks/2051ffx3xzio9.js"],"PaperListPageClient"] 2f:T407,{"@context":"https://schema.org","@type":"CollectionPage","name":"Cross-Sectional Web Analytics / Utilisation Analysis: study design Research & Clinical Takeaways","description":"Explore peer-reviewed papers on Cross-Sectional Web Analytics / Utilisation Analysis (study design). Clinician-written summaries and actionable practice insights. Updated daily.","url":"https://www.reachrx.ai/hub/tag/study_design/Cross-Sectional%20Web%20Analytics%20%2F%20Utilisation%20Analysis","breadcrumb":{"@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https://www.reachrx.ai"},{"@type":"ListItem","position":2,"name":"Research Hub","item":"https://www.reachrx.ai/hub"},{"@type":"ListItem","position":3,"name":"Study Designs","item":"https://www.reachrx.ai/hub/tag/study_design"},{"@type":"ListItem","position":4,"name":"Cross-Sectional Web Analytics / Utilisation Analysis","item":"https://www.reachrx.ai/hub/tag/study_design/Cross-Sectional%20Web%20Analytics%20%2F%20Utilisation%20Analysis"}]}}31:T78d,Abortion is a critical health service in Canada, yet access to evidence-based healthcare professional information remains limited. Our team developed a registration-based web platform in 2018, and subsequently an open-access platform in 2024 as an enhancement. The goal of these platforms was to disseminate reliable abortion-related healthcare professional information. This study examined the reach and utilisation of these platforms to assess their impact on improving access to evidence-based abortion information. We analysed secondary data extracted from the two web-based platforms. We calculated the total subscribers and analysed the user-posted queries in the registration-based platforms. We also calculated the active users, page-level access statistics, average session duration, and resource download counts in the open-access platform. The registration-based platform (2018-2025) gained 1778 subscribers over 7 years, while the open-access platform (2024-2025) reached 1379 active users in just 1 year. The use of the registration-based platform was limited to Canada, whereas the open-access website attracted both Canadian (86.9%) and international users (13.1%). The registration-based platform generated 260 user queries across 10 thematic areas, primarily from medical doctors and nurse practitioners. On the open-access platform, users spent an average of 2 minutes per visit and viewed about 4.1 pages. Our analysis shows that while the open-access platform was accessible to a broad range of providers, it did not facilitate clinical queries or active engagement. This limits opportunities for providers to seek expert advice beyond the information available on the platform. Although integrating interactive features into open-access abortion platforms currently raises privacy and security concerns, future technological advancements may enable safe and confidential provider interactions in such settings.32:T9da, Background Abortion is a critical health service in Canada, yet access to evidence-based healthcare professional information remains limited. Our team developed a registration-based web platform in 2018, and subsequently an open-access platform in 2024 as an enhancement. The goal of these platforms was to disseminate reliable abortion-related healthcare professional information. This study examined the reach and utilisation of these platforms to assess their impact on improving access to evidence-based abortion information. Methods We analysed secondary data extracted from the two web-based platforms. We calculated the total subscribers and analysed the user-posted queries in the registration-based platforms. We also calculated the active users, page-level access statistics, average session duration, and resource download counts in the open-access platform. Results The registration-based platform (2018–2025) gained 1778 subscribers over 7 years, while the open-access platform (2024–2025) reached 1379 active users in just 1 year. The use of the registration-based platform was limited to Canada, whereas the open-access website attracted both Canadian (86.9%) and international users (13.1%). The registration-based platform generated 260 user queries across 10 thematic areas, primarily from medical doctors and nurse practitioners. On the open-access platform, users spent an average of 2 minutes per visit and viewed about 4.1 pages. Conclusions Our analysis shows that while the open-access platform was accessible to a broad range of providers, it did not facilitate clinical queries or active engagement. This limits opportunities for providers to seek expert advice beyond the information available on the platform. Although integrating interactive features into open-access abortion platforms currently raises privacy and security concerns, future technological advancements may enable safe and confidential provider interactions in such settings. 25:[[["$","script","0",{"type":"application/ld+json","dangerouslySetInnerHTML":{"__html":"$2f"}}]],["$","$L30",null,{"title":"Cross-Sectional Web Analytics / Utilisation Analysis: Research & Clinical Takeaways","description":"Browse Cross-Sectional Web Analytics / Utilisation Analysis research papers with clear, practical takeaways for your clinical practice.","papers":[{"doi":"10.1136/bmjsrh-2026-203242","pmid":"42091225","title":"Web-based mentorship resources for improving access to abortion information in Canada: a utilisation and reach analysis","journal_title":"BMJ Sexual & Reproductive Health","journal_issn":"2515-1991","published_at":"2026-05-07T00:00:00.000Z","url":"https://doi.org/10.1136/bmjsrh-2026-203242","source_score":5,"is_retracted":false,"is_open_access":false,"raw_metadata":{"ooir":{"day":"2026-05-11","doi":"10.1136/bmjsrh-2026-203242","days":"7","issn":"2515-1991","rank":"6","field":"Clinical Medicine","score":"5","category":"Obstetrics & Gynecology","categories":["Obstetrics & Gynecology"],"_categories":["Obstetrics & Gynecology"]},"pubmed":{"doi":"10.1136/bmjsrh-2026-203242","title":"Web-based mentorship resources for improving access to abortion information in Canada: a utilisation and reach analysis.","journal":"BMJ sexual & reproductive health","methods":"","results":"The registration-based platform (2018-2025) gained 1778 subscribers over 7 years, while the open-access platform (2024-2025) reached 1379 active users in just 1 year. The use of the registration-based platform was limited to Canada, whereas the open-access website attracted both Canadian (86.9%) and international users (13.1%). The registration-based platform generated 260 user queries across 10 thematic areas, primarily from medical doctors and nurse practitioners. On the open-access platform, users spent an average of 2 minutes per visit and viewed about 4.1 pages.","abstract":"$31","keywords":["Abortifacient Agents","Abortion, Therapeutic","Reproductive Health","abortion, induced"],"pubmed_id":"42091225","conclusions":"","publication_date":"2026-05-07T00:00:00"},"crossref":{"DOI":"10.1136/bmjsrh-2026-203242","URL":"https://doi.org/10.1136/bmjsrh-2026-203242","ISSN":["2515-1991","2515-2009"],"link":[{"URL":"https://syndication.highwire.org/content/doi/10.1136/bmjsrh-2026-203242","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"page":"bmjsrh-2026-203242","type":"journal-article","issue":null,"score":1,"title":["Web-based mentorship resources for improving access to abortion information in Canada: a utilisation and reach analysis"],"author":[{"given":"Parita","family":"Mehta","sequence":"first","affiliation":[{"name":"Department of Neuroscience, The University of British Columbia, Vancouver, British Columbia, Canada"}]},{"given":"Wendy V","family":"Norman","sequence":"additional","affiliation":[{"name":"Department of Family Practice, The University of British Columbia Faculty of Medicine, Vancouver, British Columbia, Canada"}]},{"given":"Abdul-Fatawu","family":"Abdulai","sequence":"additional","affiliation":[{"name":"School of Nursing, The University of British Columbia, Vancouver, British Columbia, Canada"}]}],"funder":[{"name":"Health Canada Sexual and Reproductive Health Fund Health Care Policy and Strategies Program","award":["GR026692"],"award-info":[{"award-number":["GR026692"]}]}],"issued":{"date-parts":[[2026,5,6]]},"member":"239","prefix":"10.1136","source":"Crossref","volume":null,"created":{"date-time":"2026-05-06T17:20:18Z","timestamp":1778088018000,"date-parts":[[2026,5,6]]},"indexed":{"date-time":"2026-05-06T18:10:45Z","timestamp":1778091045351,"date-parts":[[2026,5,6]]},"subject":[],"abstract":"$32","accepted":{"date-parts":[[2026,4,14]]},"language":"en","relation":{},"resource":{"primary":{"URL":"https://jfprhc.bmj.com/lookup/doi/10.1136/bmjsrh-2026-203242"}},"subtitle":[],"deposited":{"date-time":"2026-05-06T17:20:23Z","timestamp":1778088023000,"date-parts":[[2026,5,6]]},"issn-type":[{"type":"print","value":"2515-1991"},{"type":"electronic","value":"2515-2009"}],"published":{"date-parts":[[2026,5,6]]},"publisher":"BMJ","reference":[{"DOI":null,"key":"2026050610200962000_bmjsrh-2026-203242v1.1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":"World Health Organization (WHO) . Abortion care guideline. 2022. Available: https://www.who.int/publications/i/item/9789240039483 [Accessed 8 Jan 2026].","article-title":null,"journal-title":null,"doi-asserted-by":null},{"DOI":"10.1016/j.contraception.2011.06.009","key":"2026050610200962000_bmjsrh-2026-203242v1.2","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":"10.1016/S1701-2163(16)30074-3","key":"2026050610200962000_bmjsrh-2026-203242v1.3","year":"2015","issue":null,"author":"Black","volume":"37","first-page":"1086","unstructured":null,"article-title":"The Cost of Unintended Pregnancies in Canada: Estimating Direct Cost, Role of Imperfect Adherence, and the Potential Impact of Increased Use of Long-Acting Reversible Contraceptives","journal-title":"J Obstet Gynaecol Can","doi-asserted-by":"crossref"},{"DOI":null,"key":"2026050610200962000_bmjsrh-2026-203242v1.4","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":"Government of Canada . Regulatory decision summary for mifegymiso. Available: https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00032 [Accessed 8 Jan 2026].","article-title":null,"journal-title":null,"doi-asserted-by":null},{"DOI":null,"key":"2026050610200962000_bmjsrh-2026-203242v1.5","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":"Grant K . Long-awaited abortion pill Mifegymiso makes Canadian debut - the Globe and Mail. Available: https://www.theglobeandmail.com/news/national/long-awaited-abortion-pill-mifegymiso-rolls-out-in-canada/article33695167/?ref=http://www.theglobeandmail.com [Accessed 31 Jan 2026].","article-title":null,"journal-title":null,"doi-asserted-by":null},{"DOI":null,"key":"2026050610200962000_bmjsrh-2026-203242v1.6","year":"2019","issue":null,"author":null,"volume":"59","first-page":"E18","unstructured":null,"article-title":"The use of mifepristone for medical abortion","journal-title":"Aust N Z J Obstet Gynaecol","doi-asserted-by":null},{"DOI":"10.5694/mja12.10297","key":"2026050610200962000_bmjsrh-2026-203242v1.7","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":null,"key":"2026050610200962000_bmjsrh-2026-203242v1.8","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":"Australian Government. Administration Departmeng of Health, Disability and Ageing. Therapeutic Goods Administration . MS-2 Step composite pack [MIFEPRISTONE LINEPHARMA 200 MG TABLET mifepristone 200 mg tablet blister; GyMiso misoprostol 200 microgram tablet blister] (210574). 2022. Available: https://www.tga.gov.au/resources/artg/210574 [Accessed 31 Jan 2026].","article-title":null,"journal-title":null,"doi-asserted-by":null},{"DOI":"10.1370/afm.2562","key":"2026050610200962000_bmjsrh-2026-203242v1.9","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":"10.1136/bmjsrh-2024-202379","key":"2026050610200962000_bmjsrh-2026-203242v1.10","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":"10.1056/NEJMsa2109779","key":"2026050610200962000_bmjsrh-2026-203242v1.11","year":"2022","issue":null,"author":"Schummers","volume":"386","first-page":"57","unstructured":null,"article-title":"Abortion Safety and Use with Normally Prescribed Mifepristone in Canada","journal-title":"N Engl J Med","doi-asserted-by":"crossref"},{"DOI":"10.1016/j.contraception.2022.03.020","key":"2026050610200962000_bmjsrh-2026-203242v1.12","year":"2022","issue":null,"author":"Ennis","volume":"113","first-page":"19","unstructured":null,"article-title":"Provision of first-trimester medication abortion in 2019: Results from the Canadian abortion provider survey","journal-title":"Contraception","doi-asserted-by":"crossref"},{"DOI":null,"key":"2026050610200962000_bmjsrh-2026-203242v1.13","year":"2022","issue":null,"author":"Norman","volume":"44","first-page":"622","unstructured":null,"article-title":"Mifepristone’s Effect on the Abortion Workforce and Rural Services in Ontario","journal-title":"J Obstet Gynaecol Can","doi-asserted-by":null},{"DOI":null,"key":"2026050610200962000_bmjsrh-2026-203242v1.14","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":"Canadian Agency for Drugs and Technologies in Health . Clinical Review Report: Mifepristone and Misoprostol (Mifegymiso). 2017. Available: https://www.ncbi.nlm.nih.gov/books/NBK534594/","article-title":null,"journal-title":null,"doi-asserted-by":null},{"DOI":"10.2196/34302","key":"2026050610200962000_bmjsrh-2026-203242v1.15","year":"2022","issue":null,"author":"Dunn","volume":"24","first-page":null,"unstructured":null,"article-title":"A Virtual Community of Practice to Support Physician Uptake of a Novel Abortion Practice: Mixed Methods Case Study","journal-title":"J Med Internet Res","doi-asserted-by":"crossref"},{"DOI":null,"key":"2026050610200962000_bmjsrh-2026-203242v1.16","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":"Contraception and Abortion Research Team-Groupe de recherche sur l’avortement et la contraception (CART-GRAC) . About us. Available: https://cart-grac.ubc.ca/about-us/ [Accessed 6 Oct 2023].","article-title":null,"journal-title":null,"doi-asserted-by":null},{"DOI":null,"key":"2026050610200962000_bmjsrh-2026-203242v1.17","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":"CAPS CPCA Forum. Available: https://caps-cpca.ubc.ca/index.php?title=Main_Page [Accessed 7 Sep 2023].","article-title":null,"journal-title":null,"doi-asserted-by":null},{"DOI":"10.2196/63364","key":"2026050610200962000_bmjsrh-2026-203242v1.18","year":"2025","issue":null,"author":"Abdulai","volume":"12","first-page":null,"unstructured":null,"article-title":"A Health Professional Mentorship Platform to Improve Equitable Access to Abortion: Development, Usability, and Content Evaluation","journal-title":"JMIR Hum Factors","doi-asserted-by":"crossref"},{"DOI":null,"key":"2026050610200962000_bmjsrh-2026-203242v1.19","year":"2024","issue":null,"author":"Abdulai","volume":"315","first-page":"392","unstructured":null,"article-title":"Intersectionality in Developing a Virtual Community of Practice Platform on Abortion","journal-title":"Stud Health Technol Inform","doi-asserted-by":null},{"DOI":"10.1177/160940691000900303","key":"2026050610200962000_bmjsrh-2026-203242v1.20","year":"2010","issue":null,"author":"Rapport","volume":"9","first-page":"270","unstructured":null,"article-title":"Summative Analysis: A Qualitative Method for Social Science and Health Research","journal-title":"Int J Qual Methods","doi-asserted-by":"crossref"},{"DOI":"10.1016/j.jogc.2016.04.005","key":"2026050610200962000_bmjsrh-2026-203242v1.21","year":"2016","issue":null,"author":"Soon","volume":"38","first-page":"636","unstructured":null,"article-title":"Medications Used in Evidence-Based Regimens for Medical Abortion: An Overview","journal-title":"J Obstet Gynaecol Can","doi-asserted-by":"crossref"},{"DOI":"10.1016/j.contraception.2020.03.021","key":"2026050610200962000_bmjsrh-2026-203242v1.22","year":"2020","issue":null,"author":"Yalahow","volume":"101","first-page":"359","unstructured":null,"article-title":"Trends in medication abortion provision before and after the introduction of mifepristone: A study of National Abortion Federation Canada member services","journal-title":"Contraception","doi-asserted-by":"crossref"},{"DOI":null,"key":"2026050610200962000_bmjsrh-2026-203242v1.23","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":"Daniels J . From crisis pregnancy centers to teenbreaks.com: anti-abortion activism’s use of cloaked websites. In: Cyberactivism on the Participatory Web. Routledge, 2014.","article-title":null,"journal-title":null,"doi-asserted-by":null},{"DOI":"10.1177/11786329241303379","key":"2026050610200962000_bmjsrh-2026-203242v1.24","year":"2024","issue":null,"author":"Mensah","volume":"17","first-page":null,"unstructured":null,"article-title":"Health Professionals’ Ethical, Security, and Patient Safety Concerns Using Digital Health Technologies: A Mixed Method Research Study","journal-title":"Health Serv Insights","doi-asserted-by":"crossref"},{"DOI":"10.1136/bmjsrh-2024-202379","key":"2026050610200962000_bmjsrh-2026-203242v1.25","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":null,"key":"2026050610200962000_bmjsrh-2026-203242v1.26","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":"The Society of Obstetricians and Gynaecologists of Canada (SOGC) . Abortion. Available: https://sogc.org/en/en/content/events/HUB-Pages/Abortion.aspx [Accessed 7 Jan 2026].","article-title":null,"journal-title":null,"doi-asserted-by":null},{"DOI":null,"key":"2026050610200962000_bmjsrh-2026-203242v1.27","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":"Guilbert E . Canadian protocol for the provision of medical abortion via telemedicine. 2020. Available: https://policycommons.net/artifacts/1751054/canadian-protocol-for-the-provision-of-medical-abortion-via-telemedicine/2482938/","article-title":null,"journal-title":null,"doi-asserted-by":null},{"DOI":"10.1136/bmjsrh-2023-202083","key":"2026050610200962000_bmjsrh-2026-203242v1.28","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":"10.1145/1835449.1835513","key":"2026050610200962000_bmjsrh-2026-203242v1.29","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":"Liu C , White RW , Dumais S . Understanding web browsing behaviors through weibull analysis of dwell time. SIGIR ’10; Geneva Switzerland, July 19, 2010:379–86. doi:10.1145/1835449.1835513","article-title":null,"journal-title":null,"doi-asserted-by":"crossref"},{"DOI":"10.1146/annurev-publhealth-082619-102442","key":"2026050610200962000_bmjsrh-2026-203242v1.30","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":null,"key":"2026050610200962000_bmjsrh-2026-203242v1.31","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":"Office of the Privacy Commissioner of Canada . Seizing opportunity: good privacy practices for developing mobile apps. 2012. Available: https://www.priv.gc.ca/en/privacy-topics/technology/mobile-and-digital-devices/mobile-apps/gd_app_201210/ [Accessed 8 Jan 2026].","article-title":null,"journal-title":null,"doi-asserted-by":null}],"short-title":[],"update-policy":"https://doi.org/10.1136/crossmarkpolicy","alternative-id":["10.1136/bmjsrh-2026-203242"],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"original-title":[],"container-title":["BMJ Sexual & Reproductive Health"],"reference-count":31,"published-online":{"date-time":null,"timestamp":null,"date-parts":[[2026,5,6]]},"references-count":31,"short-container-title":["BMJ Sex Reprod Health"],"is-referenced-by-count":0},"unpaywall":{"doi":"10.1136/bmjsrh-2026-203242","is_oa":false,"title":"Web-based mentorship resources for improving access to abortion information in Canada: a utilisation and reach analysis","updated":"2026-05-07T14:04:23+00:00","published_date":"2026-05-06","best_oa_location":null}},"created_at":"2026-05-14T13:22:54.947Z","updated_at":"2026-05-14T15:13:26.918Z","tags":[{"paper_doi":"10.1136/bmjsrh-2026-203242","tag_type":"age_group","value":"adult","value_numeric":null},{"paper_doi":"10.1136/bmjsrh-2026-203242","tag_type":"category","value":"Obstetrics & Gynecology","value_numeric":null},{"paper_doi":"10.1136/bmjsrh-2026-203242","tag_type":"condition","value":"Abortion Care","value_numeric":null},{"paper_doi":"10.1136/bmjsrh-2026-203242","tag_type":"impact_flag","value":"limited_evidence","value_numeric":null},{"paper_doi":"10.1136/bmjsrh-2026-203242","tag_type":"level_of_evidence","value":"5","value_numeric":null},{"paper_doi":"10.1136/bmjsrh-2026-203242","tag_type":"modality","value":"Digital Health Education Platform","value_numeric":null},{"paper_doi":"10.1136/bmjsrh-2026-203242","tag_type":"sample_size","value":"n=3157","value_numeric":3157},{"paper_doi":"10.1136/bmjsrh-2026-203242","tag_type":"sex","value":"mixed","value_numeric":null},{"paper_doi":"10.1136/bmjsrh-2026-203242","tag_type":"study_design","value":"Cross-Sectional Study","value_numeric":null},{"paper_doi":"10.1136/bmjsrh-2026-203242","tag_type":"study_design","value":"Cross-Sectional Web Analytics / Utilisation Analysis","value_numeric":null},{"paper_doi":"10.1136/bmjsrh-2026-203242","tag_type":"warning","value":"Multiple usage counts are presented; there is no single definable sample size.","value_numeric":null},{"paper_doi":"10.1136/bmjsrh-2026-203242","tag_type":"warning","value":"Outcomes are platform usage metrics; no patient or clinical outcome data are reported.","value_numeric":null},{"paper_doi":"10.1136/bmjsrh-2026-203242","tag_type":"warning","value":"Study design inferred from descriptive web analytics; classification may not map cleanly to a standard design.","value_numeric":null},{"paper_doi":"10.1136/bmjsrh-2026-203242","tag_type":"warning","value":"Study design is a descriptive utilisation analysis of secondary platform data — no clinical outcomes or user experience data are reported.","value_numeric":null},{"paper_doi":"10.1136/bmjsrh-2026-203242","tag_type":"warning","value":"The combined sample size tag (n=3157) sums two distinct user cohorts across different platforms and time periods; direct comparison should be made cautiously.","value_numeric":null},{"paper_doi":"10.1136/bmjsrh-2026-203242","tag_type":"warning","value":"User profession data (medical doctors, nurse practitioners) was only reported for the registration-based platform; open-access user demographics are largely unknown.","value_numeric":null}],"summaries":{"limitations":"- Secondary data analysis only; no outcomes data on whether information improved clinical practice.\n- Open-access platform lacked interactive features, preventing direct provider-expert engagement.\n- No demographic breakdown of open-access users beyond country of origin.","what_studied":"Secondary data from two abortion information platforms for clinicians were analyzed: a registration-based site (2018–2025) and a newer open-access site (2024–2025), assessing subscribers, user queries, active users, page views, session time, and downloads.","key_result":"The registration-based platform accrued 1778 subscribers over 7 years and 260 clinical queries across 10 themes, mainly from physicians and nurse practitioners. The open-access site reached 1379 active users in 1 year (86.9% Canada, 13.1% international), with about 2 minutes per visit and 4.1 pages viewed, but it did not enable clinical queries or active engagement.","practice_takeaway":"Open-access platforms can broaden reach for abortion-related clinical information but function mainly as read-only resources. Clinicians seeking case-specific guidance may need registration-based platforms that support confidential clinical queries."}}],"initialOffset":1,"fetchConfig":{"kind":"tags","tags":[{"tag_type":"study_design","value":"Cross-Sectional Web Analytics / Utilisation Analysis"}]},"breadcrumbItems":[{"name":"Home","href":"/"},{"name":"Research Hub","href":"/hub"},{"name":"Study Designs","href":"/hub/tag/study_design"},{"name":"Cross-Sectional Web Analytics / Utilisation Analysis"}],"hrefConfig":{"basePath":"/hub/papers","webViewQueryParams":{"hub_ctx":"tag","hub_tag_type":"study_design","hub_tag_value":"Cross-Sectional Web Analytics / Utilisation Analysis"}}}]]

Papers